ACST logo

Acasti Pharma Inc. Stock Price

TSXV:ACST Community·CA$19.2m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

ACST Share Price Performance

CA$0
0.00 (0.00%)
CA$0
0.00 (0.00%)
Price CA$0

ACST Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet and good value.

4 Risks
2 Rewards

Acasti Pharma Inc. Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

US$17.2m

Other Expenses

-US$17.2m

Earnings

Last Reported Earnings
Dec 31, 2022
Next Reporting Earnings
n/a
-0.39
0%
0%
0%
View Full Analysis

About ACST

Founded
2002
Employees
n/a
CEO
Prashant Kohli
WebsiteView website
www.acastipharma.com

Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.

Recent ACST News & Updates

Acasti Pharma (CVE:ACST) Is In A Good Position To Deliver On Growth Plans

Mar 01
Acasti Pharma (CVE:ACST) Is In A Good Position To Deliver On Growth Plans

Recent updates

No updates